These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. High glucose alters actin assembly in glomerular mesangial and epithelial cells. Zhou X; Hurst RD; Templeton D; Whiteside CI Lab Invest; 1995 Sep; 73(3):372-83. PubMed ID: 7564270 [TBL] [Abstract][Full Text] [Related]
25. Cyclic nucleotides in human macrophages: effects of atrial natriuretic factor and nitroprusside on cGMP and cAMP production. Houdijk AP; Adolfs MJ; Van Leeuwen PA; Bonta IL; De Jonge HR Int J Tissue React; 1991; 13(6):287-93. PubMed ID: 1726323 [TBL] [Abstract][Full Text] [Related]
26. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Smith JB; Lincoln TM Am J Physiol; 1987 Jul; 253(1 Pt 1):C147-50. PubMed ID: 2440311 [TBL] [Abstract][Full Text] [Related]
27. Atriopeptins and nitroprusside provoke opposite changes in cGMP and cAMP levels in human macrophages. Houdijk AP; Adolfs MJ; Bonta IL; De Jonge HR Eur J Pharmacol; 1990 Apr; 179(3):413-7. PubMed ID: 1694768 [TBL] [Abstract][Full Text] [Related]
28. Effects of vasoactive agents on uptake of immunoglobulin G complexes by mesangial cells. Singhal PC; Santiago A; Satriano J; Hays RM; Schlondorff D Am J Physiol; 1990 Mar; 258(3 Pt 2):F589-96. PubMed ID: 2156448 [TBL] [Abstract][Full Text] [Related]
29. Effects of ANP, angiotensin, vasopressin, and endothelin on ANP receptors in cultured rat vascular smooth muscle cells. Schiffrin EL; Turgeon A; Tremblay J; Deslongchamps M Am J Physiol; 1991 Jan; 260(1 Pt 2):H58-65. PubMed ID: 1847018 [TBL] [Abstract][Full Text] [Related]
30. Characterization of VIP and PACAP receptors in cultured rat penis corpus cavernosum smooth muscle cells and their interaction with guanylate cyclase-B receptors. Guidone G; Müller D; Vogt K; Mukhopadhyay AK Regul Pept; 2002 Oct; 108(2-3):63-72. PubMed ID: 12220728 [TBL] [Abstract][Full Text] [Related]
31. Atrial natriuretic peptide elevates cGMP contents in glomeruli and in distal tubules of rat kidney. Takeda S; Kusano E; Murayama N; Asano Y; Hosoda S; Sokabe H; Kawashima H Biochem Biophys Res Commun; 1986 May; 136(3):947-54. PubMed ID: 3013175 [TBL] [Abstract][Full Text] [Related]
32. Role of cytoskeleton in shear stress-induced endothelial nitric oxide production. Knudsen HL; Frangos JA Am J Physiol; 1997 Jul; 273(1 Pt 2):H347-55. PubMed ID: 9249510 [TBL] [Abstract][Full Text] [Related]
33. The actin cytoskeleton facilitates complement-mediated activation of cytosolic phospholipase A2. Cybulsky AV; Takano T; Papillon J; Khadir A; Bijian K; Le Berre L Am J Physiol Renal Physiol; 2004 Mar; 286(3):F466-76. PubMed ID: 14644750 [TBL] [Abstract][Full Text] [Related]
34. Effect of adenosine 3',5'-cyclic monophosphate on volume and cytoskeleton of MDCK cells. Mills JW; Lubin M Am J Physiol; 1986 Feb; 250(2 Pt 1):C319-24. PubMed ID: 3006500 [TBL] [Abstract][Full Text] [Related]
35. Atrial natriuretic peptide effects on cGMP and cAMP contents in microdissected glomeruli and segments of the rat and rabbit nephrons. Chabardès D; Montégut M; Mistaoui M; Butlen D; Morel F Pflugers Arch; 1987 Apr; 408(4):366-72. PubMed ID: 2438641 [TBL] [Abstract][Full Text] [Related]
36. Regulation of cGMP synthesis in cultured podocytes by vasoactive hormones. Lewko B; Gołos M; Latawiec E; Angielski S; Stepinski J J Physiol Pharmacol; 2006 Dec; 57(4):599-610. PubMed ID: 17229984 [TBL] [Abstract][Full Text] [Related]
37. Immunofluorescence demonstration of tubulin and actin in estrogen-induced rat prolactinoma cells in vitro. Alteration of their distribution after bromocriptine, colchicine and cytochalasin B treatments. Niwa J; Mori M; Minase T; Hashi K Exp Cell Res; 1985 Dec; 161(2):517-24. PubMed ID: 3905419 [TBL] [Abstract][Full Text] [Related]
38. Dual mechanism of angiotensin II inhibits ANP-induced mesangial cGMP accumulation. Haneda M; Kikkawa R; Maeda S; Togawa M; Koya D; Horide N; Kajiwara N; Shigeta Y Kidney Int; 1991 Aug; 40(2):188-94. PubMed ID: 1719265 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization. Delpy E; le Monnier de Gouville AC Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060 [TBL] [Abstract][Full Text] [Related]
40. cGMP antagonizes angiotensin-mediated phosphatidylcholine hydrolysis and C kinase activation in mesangial cells. Barnett RL; Ruffini L; Ramsammy L; Pasmantier R; Friedlaender MM; Nord EP Am J Physiol; 1995 Feb; 268(2 Pt 1):C376-81. PubMed ID: 7864076 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]